Michael Seth Wolf

Michael Seth Wolf

Auto-generated profile, based on publicly available information

Michael Seth Wolf

Division of Critical Care Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2023 in Critical Care Medicine
Verified
Journal Article
Closed access
JLJennifer C. Laws
Jennifer C. Laws
EVE. Haley Dnp Vance
E. Haley Dnp Vance
KBKristina A. Betters
Kristina A. Betters
JAJessica J. Anderson
Jessica J. Anderson
SFSydney Ba Fleishman
Sydney Ba Fleishman
MWMichael S. Wolf
Michael S. Wolf
OBJECTIVES: The acute cerebral physiologic effects of ketamine in children have been incompletely described. We assessed the acute effects of ketamine on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) in children with severe traumatic brain injury (TBI). DESIGN: In this retrospective observational study, patients received bolus doses of ketamine for sedation or as a treatment for ICP crisis (ICP > 20 mm Hg for > 5 min). Administration times were synchronized with ICP and CPP recordings at 1-minute intervals logged in an automated database within the electronic health record. ICP and CPP were each averaged in epochs following drug administration and compared with baseline values. Age-based CPP thresholds were subtracted from CPP recordings and compared with baseline values. Trends in ICP and CPP over time were assessed using generalized least squares regression. SETTING: A 30-bed tertiary care children’s hospital PICU. PATIENTS: Children with severe TBI who underwent ICP monitoring. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We analyzed data from 33 patients, ages 1 month to 16 years, 22 of whom received bolus doses of ketamine, with 127 doses analyzed. Demographics, patient, and injury characteristics were similar between patients who did versus did not receive ketamine boluses. In analysis of the subset of ketamine doses used only for sedation, there was no significant difference in ICP or CPP from baseline. Eighteen ketamine doses were given during ICP crises in 11 patients. ICP decreased following these doses and threshold-subtracted CPP rose. CONCLUSIONS: In this retrospective, exploratory study, ICP did not increase following ketamine administration. In the setting of a guidelines-based protocol, ketamine was associated with a reduction in ICP during ICP crises. If these findings are reproduced in a larger study, ketamine may warrant consideration as a treatment for intracranial hypertension in children with severe TBI.

2 February 2022 in Pediatric Neurology
Verified
Journal Article
Closed access
JLJennifer C. Laws
Jennifer C. Laws
LJLori C. Jordan
Lori C. Jordan
LPLindsay M. Pagano
Lindsay M. Pagano
JWJohn C. Wellons
John C. Wellons
MWMichael S. Wolf
Michael S. Wolf

15 April 2025 in POCUS Journal
Verified
Journal Article
Open access
PDF file
AMAlonso Marron
Alonso Marron
MWMichael Wolf
Michael Wolf
MLMarla Levine
Marla Levine
JBJeremy Boyd
Jeremy Boyd
MHMarta Hernanz-Schulman
Marta Hernanz-Schulman
The aim of this study was to investigate the role of point of care ultrasound (POCUS) as an alternative imaging modality to confirm the location of gastric and post-pyloric feeding tubes in patients admitted to the pediatric intensive care unit (PICU). This was a prospective descriptive study performed at a tertiary care children’s hospital. Patients from birth to 17 years of age in whom the medical team placed a temporary enteral feeding tube were eligible for enrollment. The study physician, who was blinded to the radiographic findings, performed a POCUS study of the abdomen. An abdominal radiograph was obtained to confirm the placement in all patients. A total of 13 patients were enrolled, and 14 abdominal POCUS exams were completed. POCUS accurately identified the location of the enteral feeding tube in 10 of the 14 cases. POCUS had a sensitivity and specificity of 85.7% and 57.1%, respectively, in identifying gastric tubes. It had a sensitivity and specificity of 66.7% and 87.5%, respectively, in identifying post-pyloric tubes. No adverse events were reported. This study showed that POCUS had moderate sensitivity and specificity and was, overall, safe. Further studies can assess the level of training needed for improvement in accuracy, and larger studies can help support the findings of this data that POCUS is a safe and accurate alternative to radiographs for enteral feeding tube placement confirmation.

15 August 2025 in Neurocritical Care
Verified
Journal Article
Open access
JLJennifer Clancy Laws
Jennifer Clancy Laws
JRJaskaran Rakkar
Jaskaran Rakkar
SBSandra D. W. Buttram
Sandra D. W. Buttram
MWMichael Seth Wolf
Michael Seth Wolf
Background: Sedative, analgesia, and neuromuscular blocking (NMB) medications may be necessary in the acute management of pediatric severe traumatic brain injury (sTBI), yet limited data exist to guide their use. We aimed to describe the use of continuous infusions of these medications in children with sTBI, to determine temporal trends during the first week of management, and to evaluate associations with in-hospital mortality. Methods: We conducted a secondary analysis of the Approaches and Decisions in Acute Pediatric Traumatic Brain Injury Trial (NCT04077411, 2014–2017), a prospective multicenter observational study of patients < 18 years old with sTBI (Glasgow Coma Scale ≤ 8) who underwent intracranial pressure monitoring. Continuous analgesic, sedative, and NMB medication infusions administered in the first 7 days after sTBI were analyzed. Results: Data from 929 patients were analyzed with a median Glasgow Coma Scale of 6 (interquartile range 3–7), 14% hospital mortality. In the 7 days after intracranial pressure monitor placement, 866 (93%) patients received an opioid infusion, with 659 (71%) patients having received fentanyl. A total of 679 (73%) patients received benzodiazepine: 671 (72%) patients received midazolam. A total of 362 (39%) patients received NMB, with the most common being vecuronium, administered to 141 (15%) patients. Propofol was administered to 264 (28%) patients, alpha-2 agonist to 263 (28%) patients, and ketamine to 4 (0.43%) patients. The median number of infusions per patient was 2 (interquartile range 1–2), with the highest number on intensive care unit day 2. Morphine and dexmedetomidine infusions were used more often in survivors than nonsurvivors (33 vs. 16%, and 30 vs. 9%, respectively, p < 0.001). Conclusions: Fentanyl and midazolam were the most common analgesic and sedative continuous infusions during acute pediatric sTBI management. Propofol and dexmedetomidine were used less frequently. Opioid (specifically morphine) and dexmedetomidine infusions were associated with survival. Larger studies are needed to determine the safest and most effective analgesia, sedation, and NMB medication strategy for children with sTBI.

3 June 2024 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
MWMichael S. Wolf
Michael S. Wolf
Children and adolescents hospitalized with infectious and inflammatory conditions are at risk of neurological sequelae, presenting clinicians with the

12 April 2021 in Pediatric Research
Verified
Journal Article
Open access
PDF file
MWMichael S. Wolf
Michael S. Wolf
MMMioara D. Manole
Mioara D. Manole
LNLee Ann New
Lee Ann New
YCYaming Chen
Yaming Chen
ESElif Soysal
Elif Soysal
RCRobert Clark
Robert Clark
Background Asphyxial cardiac arrest (CA) is a significant cause of death and disability in children. Using juvenile Osteogenic disorder Shionogi (ODS) rats that, like humans, do not synthesize ascorbate, we tested the effect of ascorbate deficiency on functional and histological outcome after CA. Methods Postnatal day 16–18 milk-fed ODS and wild-type Wistar rats underwent 9-min asphyxial CA (n = 8/group) or sham surgery (n = 4/group). ODS mothers received ascorbate in drinking water to prevent scurvy. Levels of ascorbate and glutathione (GSH) were measured in plasma and hippocampus at baseline and after CA. Neurologic deficit score (NDS) was measured at 3, 24, and 48 h and hippocampal neuronal counts, neurodegeneration, and microglial activation were assessed at day 7. Results ODS rats showed depletion of plasma and hippocampal ascorbate, attenuated hippocampal neurodegeneration and microglial activation, and increased CA1 hippocampal neuron survival vs. Wistar rats while NDS were similar. Hippocampal GSH levels were higher in ODS vs. Wistar rats at baseline and 10 min, whereas hypoxia-inducible factor-1α levels were higher in Wistar vs. ODS rats at 24 , after CA. Conclusion Ascorbate-deficient juvenile ODS rats appear resistant to neurodegeneration produced by asphyxia CA, possibly related to upregulation of the endogenous antioxidant GSH in brain. Impact Like humans and unlike other rodents, osteogenic disorder Shionogi (ODS) rats do not synthesize ascorbate, and thus may serve as a useful model for studying the role of ascorbate in human disease. Conflicting evidence exists regarding ascorbate’s protective versus detrimental effects in animal models and clinical studies. Ascorbate-deficient ODS rats are resistant to neurodegeneration after experimental cardiac arrest.